Hextend is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hospira, Inc.. The primary component is Hetastarch.
Product ID | 0409-1555_62a15a9b-c395-4669-b6ae-52b814d25500 |
NDC | 0409-1555 |
Product Type | Human Prescription Drug |
Proprietary Name | Hextend |
Generic Name | Hetastarch |
Dosage Form | Injection, Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2005-02-02 |
Marketing Category | NDA / NDA |
Application Number | BN200952 |
Labeler Name | Hospira, Inc. |
Substance Name | HETASTARCH |
Active Ingredient Strength | 6 g/100mL |
Pharm Classes | Plasma Volume Expander [EPC],Increased Intravascular Volume [PE],Osmotic Activity [MoA],Starch [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2005-02-02 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | BN200952 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2005-02-02 |
Marketing Category | NDA |
Application Number | BN200952 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2015-07-07 |
Ingredient | Strength |
---|---|
HETASTARCH | 6 g/100mL |
SPL SET ID: | fc79700c-6c3b-4998-8307-4dc8c81c5041 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0409-1555 | Hextend | HETASTARCH |
0409-7248 | Hetastarch in Sodium Chloride | HETASTARCH |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
HEXTEND 98714384 not registered Live/Pending |
Storyastic, LLC 2024-08-23 |
HEXTEND 74678267 1964271 Live/Registered |
BIOTIME, INC. 1995-05-22 |